Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 35.64 USD -0.75% Market Closed
Market Cap: 6.5B USD

Wall Street
Price Targets

LEGN Price Targets Summary
Legend Biotech Corp

Wall Street analysts forecast LEGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LEGN is 79.02 USD with a low forecast of 53.65 USD and a high forecast of 99.75 USD.

Lowest
Price Target
53.65 USD
51% Upside
Average
Price Target
79.02 USD
122% Upside
Highest
Price Target
99.75 USD
180% Upside
Legend Biotech Corp Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
225% Upside
87S
Roivant Sciences Ltd
66% Upside
TLX
Telix Pharmaceuticals Ltd
42% Upside
KRYS
Krystal Biotech Inc
46% Upside
BEAM
Beam Therapeutics Inc
125% Upside
STOK
Stoke Therapeutics Inc
99% Upside
002007
Hualan Biological Engineering Inc
23% Upside
SRZN
Surrozen Inc
351% Upside

Revenue
Forecast

Revenue Estimate
Legend Biotech Corp

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 3 years is 51%.

53%
Past Growth
51%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LEGN's stock price target?
Price Target
79.02 USD

According to Wall Street analysts, the average 1-year price target for LEGN is 79.02 USD with a low forecast of 53.65 USD and a high forecast of 99.75 USD.

What is Legend Biotech Corp's Revenue forecast?
Projected CAGR
51%

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 3 years is 51%.

Back to Top